featured
Acalabrutinib With or Without Obinutuzumab vs Zanubrutinib Monotherapy for Treatment-Naïve CLL Without Del(17p)
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL
Blood Adv 2024 Apr 10;[EPub Ahead of Print], AS Kittai, JN Allan, D James, H Bridge, M Miranda, AS Yong, F Fam, J Roos, V Shetty, AP Skarbnik, MS DavidsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.